{{Rsnum
|rsid=7028939
|Gene=ERP44
|Chromosome=9
|position=100046403
|Orientation=plus
|GMAF=0.146
|Gene_s=ERP44
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 82.3 | 16.8 | 0.9
| HCB | 98.5 | 1.5 | 0.0
| JPT | 100.0 | 0.0 | 0.0
| YRI | 27.9 | 49.7 | 22.4
| ASW | 40.4 | 47.4 | 12.3
| CHB | 98.5 | 1.5 | 0.0
| CHD | 99.1 | 0.9 | 0.0
| GIH | 94.1 | 5.9 | 0.0
| LWK | 30.9 | 47.3 | 21.8
| MEX | 94.8 | 5.2 | 0.0
| MKK | 51.0 | 41.9 | 7.1
| TSI | 83.3 | 14.7 | 2.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23551011
  |Trait=Preeclampsia
  |Title=Genome-Wide Association Study of Pre-Eclampsia Detects Novel Maternal Single Nucleotide Polymorphisms and Copy-Number Variants in Subsets of the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Cohort.
  |RiskAllele=
  |Pval=3E-6
  |OR=3.17
  |ORtxt=[1.95-5.15]
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}